Cargando…
Genetic alterations and functional networks of m6A RNA methylation regulators in pancreatic cancer based on data mining
BACKGROUND: Pancreatic cancer is a fatal malignancy of the digestive system and the 5-year survival rate remains low. Therefore, new molecular therapeutic targets are required to improve treatments, prognosis, and the survival of patients. N6-methyladenosine (m6A) is the most prevalent reversible me...
Autores principales: | Zeng, Juan, Zhang, Heying, Tan, Yonggang, Wang, Zhe, Li, Yunwei, Yang, Xianghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325265/ https://www.ncbi.nlm.nih.gov/pubmed/34330301 http://dx.doi.org/10.1186/s12967-021-03001-2 |
Ejemplares similares
-
m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling
por: Zeng, Juan, et al.
Publicado: (2021) -
Retraction Notice to: m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling
por: Zeng, Juan, et al.
Publicado: (2022) -
Subgroup analysis reveals molecular heterogeneity and provides potential precise treatment for pancreatic cancers
por: Zhang, Heying, et al.
Publicado: (2018) -
ceRNA network analysis reveals prognostic markers for glioblastoma
por: Wang, Hao, et al.
Publicado: (2019) -
MicroRNA-190b expression predicts a good prognosis and attenuates the malignant progression of pancreatic cancer by targeting MEF2C and TCF4
por: Li, Yunwei, et al.
Publicado: (2022)